The economy of the country and the world is struggling with a crisis due to the second powerful wave of coronavirus. The number of new cases in unlocking is increasing daily in India too. In such a situation, efforts to bring the Covid-19 vaccine as soon as possible have received a major blow.
AstraZeneca has stopped the trial of the vaccine Kovyshield made at Oxford University in the US because of a volunteer sick. At the same time, 9 pharmaceutical companies in the US have promised that they will not launch the premature vaccine market.
Trials of the Oxford Vaccine Stopped
The phase-3 trials of Vaccine Coveshield of Oxford University and AstraZeneca, currently leading the vaccine race, have been temporarily halted. A volunteer has become ill. It is not understood whether this is a side effect of the vaccine shot or something. AstraZeneca has begun its investigation.
The company stated on Tuesday evening, saying that the standard review process has been stopped so that the safety data can be reviewed. AstraZeneca has not mentioned anything about the possible side effects. It is only said that it is 'Potentially unexplained illness'.
Health news site STAT was the first to report this news. A spokesperson for AstraZeneca has confirmed that it is in Volunteer UK. After this, AstraZeneca has stopped Phase-3 trials all over the world including America, India.
In the past month itself, AstraZeneca has started tests on 30,000 people in the US. Apart from this, trials of this Oxford University vaccine have started in Britain, Brazil, South Africa as well as India. Serum Institute of India is conducting its trials in India.
Kovaxin will be available next year
India's first indigenous Covid-19 vaccine Kovaxin will be launched early next year. It has been developed by Bharat Biotech in association with ICMR. Kovaxin has started Phase-1 trials. The central government has approved phase-2 trials from 7 September.
Sanjay Rai, a community medicine professor at AIIMS and principal investigator of the Covid-19 vaccine, said the Phase-1 trials were successful. Phase-2 trials will be completed in October. Phase-3 trials will begin after this. This means that covaxin will be available by early 2021.
Efforts on phase-3 testing of Russian vaccine in India intensify
Russia has approached India for phase-3 trials of its Covid-19 vaccine Sputnik V and its production. NITI Aayog member Dr VK Paul said that the government understands the great importance of this offer of partnership with very special friends. There have been significant efforts on this.
Member (Health) in NITI Aayog, Dr. Paul also said that Russia had approached several companies of the country for the production of vaccines. Four companies have also come forward for this. The government is trying to see how these companies can connect with Russian authorities.
9 pharmaceutical companies promised vaccine will be safe
Nine pharmaceutical companies have issued a joint pledge, dismissing pressure to bring the Covid-19 vaccine before the US presidential elections. He has said in this that the safety of people who will be vaccinated will be at the top.
The CEOs of AstraZeneca, BioNotech, GlaxoSmithKline (GSK), Johnson & Johnson, Merck (MSD), Moderna, Novavax, Pfizer, and Sanofi have signed on to the pledge. The initiative comes at a time when US President Donald Trump is trying to get treatment and vaccine approved as soon as possible to fight the epidemic.
Trump also hinted on Monday that the US may approve the Covid-19 vaccine ahead of the presidential elections on November 3, or in October. It is clear from the pledge of nine pharmaceutical companies that none of these companies will ask for premature approval before the trial ends.
Encounter continues between security forces and terrorists in Haripora area of Shopian district, two to three terrorists surrounded
Security forces have tightened their grip on the terrorists who are trying to create unrest by targeting the common people in the Kashmir Valley. After killing two terrorists in Awantipora on
Rule Change: Changes are going to happen in these rules from today, know what will be the effect on your pocket?
New Rule From November: On November 1, many big changes are going to happen in the country, which is going to have a direct impact on the pocket of the common man. In such a situation, it is important
Manipur Violence: Strict action by security forces in Manipur 12 bunkers were destroyed in the search operation, 135 were arrested so far; Mortar-IED also recovered
Police and central security forces destroyed 12 bunkers allegedly built by militants in different districts of violence-hit Manipur in the last 24 hours. The police gave this information on Sunday.
China becomes world's richest country: overtakes America; China's wealth increased 16 times in 20 years, 3 times the world's wealth
China has become the richest country, overtaking America, which is considered the world's superpower. According to a report by the research branch of management consultant McKinsey & Company,
Meghalaya: PM Modi said- Congress considered this region as the last part of the country, we have developed the growth engine
Prime Minister Narendra Modi addressed a public meeting in Tura, Meghalaya. He said that now the G20 meeting is also going to be held in Meghalaya, due to which the identity of Meghalaya is going to
Gadkari praised former Prime Minister Manmohan Singh: Said - his economic reforms as Finance Minister gave a new direction to India
Union Minister for Road Transport and Highways Nitin Gadkari on Tuesday praised former Prime Minister Manmohan Singh. Gadkari said that the economic reforms initiated by Manmohan Singh as Finance
IPL 2025: PBKS captain Shreyas Iyer stole the show, broke MS Dhoni's big IPL record
Shreyas Iyer continued his brilliant performance as captain and with the bat. Punjab Kings won their second consecutive win in IPL 2025. The Punjab team easily defeated Lucknow Super Giants (LSG) by
Pradeep Sarkar Death: Pradeep Sarkar's upcoming film with Kangana Ranot, the superhit movies with Rani and Kajol
Pradeep Sarkar Death: A few days after the death of Satish Kaushik, Bollywood suffered another deep blow. At the age of 67, director and writer Pradeep Sarkar said goodbye to this world.
Good news: Relief news for six crore account holders of EPFO, Covid will be able to get advance for the second time
The coronavirus epidemic has spoiled the economic condition of the people of the country. The government is doing everything possible to provide relief to the people. Now the Employees Provident Fund
Jeeva Murder: Shooter shot 6 bullets to Jeeva in Lucknow court, postmortem report came, lawyers strike
Sanjeev Jeeva Murder case: In the case of the murder of Sanjeev Maheshwari alias Jeeva, a close shooter of Mukhtar Ansari, the SIT inspected the spot on Wednesday late night. The SIT has been asked to
